The decision between buying and leasing cryogenic storage equipment is a financial and operational one that affects how capital is deployed in a new or expanding IVF laboratory. There is no universally correct answer – the right choice depends on the laboratory’s financial structure, its anticipated growth rate, and whether flexibility or long-term cost efficiency is the higher priority.
The case for buying
Outright purchase of liquid nitrogen storage vessels and dry shippers gives the laboratory full ownership of the asset from day one. Over a working life of ten years or more for a well-maintained storage vessel, the total cost of ownership is typically lower than an equivalent leasing arrangement. Ownership also means no dependency on a lease provider for equipment availability or replacement decisions. For well-established private fertility groups and NHS fertility units with capital budgets, outright purchase is generally the more cost-efficient long-term approach.
The case for leasing
For a new IVF laboratory managing its initial capital carefully, leasing converts a large upfront capital cost into a predictable monthly operating expense. This can free capital for other aspects of the laboratory setup – culture media, incubators, microscopes – that also require significant investment. Some leasing arrangements include maintenance and replacement provisions that reduce the operational burden on laboratory management. For a laboratory uncertain about its exact growth trajectory, leasing also provides flexibility to scale capacity without committing to owned assets that may need to be replaced or supplemented within a short timeframe.
The leasing vs buying decision is ultimately a cash flow decision. If the capital exists and the programme is well established, buying is almost always the better long-term value. If the capital is constrained and the programme is in early growth, leasing can be a reasonable bridge that allows the laboratory to operate with appropriate equipment without delaying opening.
What does not change with either approach
Whether the equipment is owned or leased, the clinical and regulatory requirements are identical. The vessel must maintain -195.8 degrees C, the backup storage must be ready, the oxygen depletion monitor must be installed, and the traceability system must function. Leasing does not reduce the compliance requirement – it changes who owns the hardware. For capital equipment advice and pricing for both purchase and enquiry, contact the Cryolab team or use CryoGPT.
